Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $3 |
| - Cash | $2 | $3 | $5 | $0 |
| + Debt | $0 | $0 | $1 | $3 |
| Enterprise Value | – | -$2 | -$3 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$6 | $3 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$6 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.04 | -0.09 | -2.15 | -11.12 |
| % Growth | 55.6% | 95.8% | 80.7% | – |
| Operating Cash Flow | -$0 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$1 | -$1 | -$1 |